Skip to main content
Signal8

Sawaf Aziz

SEC insider (Form 3/4/5 filer). CIK 0001961289. EVP, Chief Financial Officer at Vir Biotechnology, Inc. (VIR) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SAN FRANCISCO, CA.

Companies Sawaf Aziz has filed insider reports for

  • Vir Biotechnology, Inc. (VIR): Officer, EVP, Chief Financial Officer
  • Theravance Biopharma, Inc. (TBPH): Officer, SVP & CHIEF FINANCIAL OFFICER
Sawaf Aziz profile photo

Sawaf Aziz

CIK: 0001961289

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)11 (84.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Vir Biotechnology, Inc. logo
VIR

Vir Biotechnology, Inc.

Officer
Theravance Biopharma, Inc. logo
TBPH

Theravance Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Sep 23, 2026
    Disposition
    Direct
    205K shares-
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Sep 23, 2026
    Disposition
    Direct
    23.4K shares-
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Sep 23, 2026
    Disposition
    Direct
    108.4K shares-
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Aug 20, 2026
    Tax Payment
    Direct
    8.1K shares at avg. $16.95$137K
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    May 20, 2026
    Tax Payment
    Direct
    8.7K shares at avg. $16.55$143K
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Apr 1, 2026
    Award
    Direct
    37.5K shares-
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Feb 20, 2026
    Tax Payment
    Direct
    20.7K shares at avg. $19.66$406K
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Nov 20, 2025
    Tax Payment
    Direct
    18.6K shares at avg. $17.90$333K
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    Aug 20, 2025
    Tax Payment
    Direct
    9.4K shares at avg. $13.39$125K
  • Theravance Biopharma, Inc. logo
    TBPH

    Theravance Biopharma, Inc.

    May 20, 2025
    Tax Payment
    Direct
    9.3K shares at avg. $9.45$88K

1-10 of 13